VisiCELL Medical is at the forefront of transforming disease diagnosis and treatment through its innovative theranostic nanomaterials. The company specializes in developing non-toxic, user-friendly, and cost-effective labeling solutions for immune (CAR-T, NK) and stem cells. These technologies enable researchers to accurately track the locations of therapeutic cells post-administration, akin to a GPS system for cell therapy. By providing real-time insights into product performance, VisiCELL Medical aims to streamline the research and development process, facilitating a faster transition from laboratory innovations to market-ready therapies.

Central to VisiCELL Medical's offerings is the VMI-Trac labeling system, which represents a significant advancement in the field of cell therapy. This all-in-one solution allows for the real-time tracking of injected therapeutic cells in various pre-clinical and translational applications. The VMI-Trac system has been validated across multiple immune and stem cell types, demonstrating safety and efficacy without long-term adverse effects on cellular function. With various product options tailored to specific cell tracking needs, including VMI-Trac Plus, Duo, Pro, and the upcoming Ultra, VisiCELL Medical is committed to meeting the diverse demands of cell therapy developers while ensuring the viability of labeled cells.

United States

Visicell Medical Inc. was founded by a team of passionate scientist, engineer, and radiologist with a singular goal: to help accelerate stem cell-based therapy to the market for patients who are afflicted with devastating and currently incurable diseases. Our technology platform will transform how biopharmaceutical products are developed and taken to market by offering customers clinically applicable imaging tools that can provide real-time insights for their unique individual research needs.

VisiCELL Medical

Company Details